Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver Disease

被引:67
|
作者
Mun, Jeongeun [1 ]
Kim, Shintae [1 ]
Yoon, Ho-Geun [2 ]
You, Yanghee [1 ]
Kim, Ok-Kyung [1 ]
Choi, Kyung-Chul [3 ]
Lee, Yoo-Hyun [4 ]
Lee, Jeongmin [5 ]
Park, Jeongjin [1 ]
Jun, Woojin [1 ]
机构
[1] Chonnam Natl Univ, Div Food & Nutr, Gwangju 61186, South Korea
[2] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 03722, South Korea
[3] Univ Ulsan, Dept Biomed Sci, Coll Med, Seoul 05505, South Korea
[4] Univ Suwon, Dept Food & Nutr, Gyeonggido 18323, South Korea
[5] Kyung Hee Univ, Dept Med Nutr, Gyeonggido 17104, South Korea
基金
新加坡国家研究基金会;
关键词
Curcuma longa L; non-alcoholic fatty liver disease; fatty acid uptake; lipid accumulation; oxidative stress; INDUCED OXIDATIVE STRESS; ANTIOXIDANT; DIET; EXPRESSION; PURIFICATION; GLUTATHIONE; RESISTANT; TRENDS; RATS;
D O I
10.3390/nu11102536
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Our aim was to investigate whether hot water extract (CLW) of Curcuma longa L. could prevent non-alcoholic fatty liver disease (NAFLD). HepG2 cells were treated with free fatty acid (FFA) mixture (oleic acid: palmitic acid, 2:1) for 24 h to stimulate in vitro fatty liver. In addition, C57BL/6 mice were fed 60 kcal% high-fat (HF) diet for eight weeks to induce fatty liver in vivo. Intracellular reactive oxygen species (ROS) and malondialdehyde (MDA) productions were increased by FFA and HF-diet, but supplementation with CLW significantly decreased these levels. CLW treatment ameliorated antioxidant activities that were suppressed by exposure to the FFA and HF-diet. Cluster of differentiation 36 (CD36) and fatty acid transport proteins (FATP2 and FATP5) were increased in HF-diet groups, while CLW suppressed their expression levels. Moreover, sterol regulatory element-binding protein-1c (SREBP-1c), acetyl-coenzyme A carboxylase (ACC), and fatty acid synthase (FAS) expression levels were down-regulated in the CLW groups compared to HF-diet groups. On the other hand, 5 ' adenosine monophosphate-activated protein kinase (AMPK), Peroxisome proliferator-activated receptor alpha (PPAR-alpha), and carnitine palmitoyltransferase 1 (CPT-1) expressions were up-regulated in the CLW groups. HF-diet fed mice showed high hepatic triglycerides (TG) content compared to the normal diet mice. However, the administration of CLW restored the hepatic TG level, indicating an inhibitory effect against lipid accumulation by CLW. These results suggest that CLW could be a potentially useful agent for the prevention of NAFLD through modulating fatty acid uptake.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS RELATED TO NON-ALCOHOLIC FATTY PANCREAS DISEASE (NAFPD)
    van Geenen, Erwin-Jan M.
    Smits, Mark M.
    Schreuder, Tim C.
    Bloemena, Elisabeth
    van der Peet, Donald L.
    Mulder, Chris J.
    HEPATOLOGY, 2009, 50 (04) : 788A - 788A
  • [32] Non-alcoholic fatty liver disease and liver secretome
    Khan, Muhammad Sohaib
    Lee, Choongho
    Kim, Sang Geon
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (12) : 938 - 963
  • [33] Liver transplantation and non-alcoholic fatty liver disease
    Zezos, Petros
    Renner, Eberhard L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (42) : 15532 - 15538
  • [34] Liver transplantation for non-alcoholic fatty liver disease
    Germani, Giacomo
    Becchetti, Chiara
    MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2018, 64 (02) : 138 - 146
  • [35] Non-alcoholic fatty liver disease and liver transplantation
    Khan, Reenam S.
    Newsome, Philip N.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1208 - 1223
  • [36] Non-alcoholic fatty liver disease and liver secretome
    Muhammad Sohaib Khan
    Choongho Lee
    Sang Geon Kim
    Archives of Pharmacal Research, 2022, 45 : 938 - 963
  • [37] Liver transplantation and non-alcoholic fatty liver disease
    Petros Zezos
    Eberhard L Renner
    World Journal of Gastroenterology, 2014, (42) : 15532 - 15538
  • [38] Sex difference in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Tomiya, Tomoaki
    HEPATOLOGY RESEARCH, 2010, 40 (01) : 108 - 110
  • [39] Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
    Wu, Dongqing
    Zhu, Huaqing
    Wang, Hua
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [40] PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer
    Peyrou, Marion
    Bourgoin, Lucie
    Foti, Michelangelo
    DIGESTIVE DISEASES, 2010, 28 (01) : 236 - 246